Is the drug industry changing its approach to medical cannabis? This morning, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) subsidiary Teva Israel reported signing a cooperation and marketing agreement with the Israeli company Syqe Medical to market the world’s first cannabis inhaler. No financial data on the agreement were disclosed. According to the agreement, Teva…